성민기

  #유방 양성질환#유방병리#유방암#유방암 및 유방양성질환의 영상과 조직검사

학력

2014 .09 한양대학교 의과 대학원 의학 석사
1996 .03~2004 .02 한양대학교 의과대학 졸업

경력

2014 .09 원자력병원 외과 과장
2012 .05~2014 .08 원자력병원 유방암 전임의
2005 .03~2009 .02 원자력병원 외과 전공의
2004 .03~2005 .02 원자력병원 인턴

논문

논문 2018년도 Efficacy of combined aromatase inhibitor and luteinizing hormone-releasing hormone agonist in premenopausal metastatic breast cancer Journal of Breast Disease

논문 2018년도 Post-chemothrapy anti-mullerian hormone as a predictive marker for recovery of ovarian function in participants of ASTRRA trial Endocrine Connections

논문 2018년도 Post-chemotherapy serum anti-mullerian hormone level predicts ovarian function recovery Endocrine Connections

논문 2018년도 Prediction of the tumor differentiation using sequential PET/CT and MRI in patients with breast cancer Annals of Nuclear Medicine

논문 2018년도 Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implication for serum HER2 in recurrent HER2-negative breast cancer Oncotarget

논문 2017년도 Phosphorylated S6 Kinase-1 as Predictive Marker of Lapatinib Efficacy in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients Journal of Breast Disease

논문 2017년도 Factors associated with metastatic breast cancer patients who show long-term stable disease status Journal of breast disease

논문 2017년도 The examination of ovarian reserve in premenopausal patients eith hormone receptor positive breast cancer The Ewha Medical Journal

논문 2016년도 Targeting hypoxia is an essential prerequisite for cell sensitivity to metformin and lapatinib 2016 ascb annual meeting

연구 2016년도 Prognostic effect of serum anti-mullerian hormone and inhibin B level in premenopausal hormone receptor(+) breast cancer patients treated by neoadjuvant chemotherapy -

연구 2016년도 STAT3-Survivin signaling modulates poor response to radiotherapy in HER2-positive breast cancer Oncotarget

연구 2016년도 Identification of molecules associated with tamoxifen resistance through gene expression profiling of tamoxifen-resistant breast cancer cells. Global breast cancer conference 2016

연구 2015년도 Ginkgetin induces cell death in breast cancer cells by estrogen receptor-PFKFB3 downregulation. 2016. GBCC

연구 2016년도 TRAIL overcomes the HIF1A - inhibited cell death induced by combination of DCA & Metformin Global Breast Cancer Conference 2016

연구 2016년도 Prognostic Value of Anti-Mullerian Hormone and Inhibin B in Patients with Premenopausal Hormone Receptor-positive Breast Cancer Anticancer Research

연구 2016년도 The risk factors of pregnancy-associated breast cancer in korean women GBCC

연구 2016년도 The relationship between the change of serum human epidermal growth factor receptor-2 (HER2) measurement as a tumor marker in primary HER2 negative breast cancer patients GBCC 2016

연구 2016년도 Regulation of sensitivity to dichloroacetate (DCA) and Metformin is an essential prerequisite of HIF-1a suppression Global Breast Cancer Conference 2016

논문 2016년도 Targeting HIF-1a is a prerequisite for cell sensitivity to dichloroacetate(DCA) and metformin Biochemical and Biophysical Research Communications

논문 2015년도 Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer Breast Cancer Research and Treatment

논문 2015년도 Primary apocrine sweat gland carcinomas of the axilla: a report of two cases and a review of the literature WORLD J SURG ONCOL

논문 2014년도 Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients J Breast Cancer

논문 2013년도 Phosphorylated S6 kinase-1: a breast cancer marker predicting resistance to neoadjuvant chemotherapy Anticancer Res

논문 2008년도 Apocrine Carcinoma of the Breast: Clinicopathologic Analysis of 19 Cases J Breas

저서

저서 내용이 없습니다.

보도자료

[진료실에서] 유방 재건술은 언제가 좋을까
http://news.kmib.co.kr/article/view.asp?arcid=0924061875&code=14130000&cp=nv

원자력의학원, 유방암 환자 방사선 치료 예측 지표 개발
https://www.sedaily.com/NewsView/1YXQWFLE8H

포스팅

포스팅 내용이 없습니다.

영상자료

영상자료 내용이 없습니다.

발표자료

발표자료 내용이 없습니다.